SSI INVESTMENT MANAGEMENT LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$9,431,462
-1.1%
10,872,000
-3.0%
0.77%
+15.2%
Q2 2023$9,536,859
+2.5%
11,208,000
+2.2%
0.67%
+2.3%
Q1 2023$9,305,314
-0.5%
10,967,000
-3.1%
0.65%
+10.3%
Q4 2022$9,350,416
+3.8%
11,316,000
-0.1%
0.59%
-2.0%
Q3 2022$9,006,000
+6.5%
11,327,000
+4.8%
0.60%
+13.7%
Q2 2022$8,459,000
+210.7%
10,808,000
+232.6%
0.53%
+257.0%
Q1 2022$2,723,0003,250,0000.15%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders